Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2026
SynAct Pharma and Hipolabor enter dengue-treatment partnership in Brazil
SynAct Pharma announced that it entered into a strategic co-development and commercialization agreement with Hipolabor for resomelagon as a dengue treatment in Brazil. The agreement provides for equal sharing of development costs and profits.